Banner for leaf pages 2

Meropenem

Also known as Merrem and Meronem

Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. Meropenem was originally developed by MJ Pharmaceuticals. It is marketed in India by Nirlife and Positive Medicare with the brand name Meronir and Carnem respectively & outside India by AstraZeneca with the brand names Monan and Meronem. It gained US FDA approval in July 1996. It penetrates well into many tissues and body fluids including the cerebrospinal fluid, bile, heart valves, lung, and peritoneal fluid.

Source: Wikipedia

Estimated Total Cost: $1090.75 for an average of 7 days supply

What is it prescribed for?

Patients are most commonly prescribed meropenem to treat fever, sepsis, gas gangrene, and weakness.

What drug interactions are known?

Do not take meropenem if you are taking any of the following:

Critical Interactions

Significant Interactions


What side effects are related?

Patients taking meropenem most commonly experience side effects like diarrhea, skin rash, and yeast infection.

Ajax-loader Loading...